Intellectual Property 2022-10-31 11:01 pm
Save (1) Please login to bookmarkClose Username or Email Address Password Remember Me Swiss pharmaceutical company Biogen and Australian generic drug maker Pharmacor have dropped their claims against one another in a lawsuit over the patent for MS drug Tecfidera. In an October 14 order by Federal Court Justice Helen Rofe, Biogen’s infringement claims and…